Latest News - CRSToday

Wednesday, March 22, 2017 | Product Releases, Allergan

Allergan Announces Availability of Restasis Multidose (Cyclosporine Ophthalmic Emulsion) 0.05%

Allergan announced the availability of Restasis Multidose, the first and only FDA-approved preservative-free, prescription eye drop in the United States to be available in a multidose bottle. Previous…

Read the full story

Wednesday, March 22, 2017 | Glaucoma, Partnerships, Ora

AXIM Biotech Retains ORA to Manage Glaucoma & Dry Eye Indications Product Development and Clinical Trials

Axim Biotechnologies is retaining the services from contract research organization Ora to run the company’s upcoming product development and clinical trials for the treatment of glaucoma and dry…

Read the full story

Wednesday, March 22, 2017 | Medical Studies, Ocular Therapeutix

New Publication Describes Positive Patient Experience in Study of Ocular Therapeutix’ Dextenza Following Cataract Surgery

Ocular Therapeutix announced positive results of a patient experience study of Dextenza (dexamethasone insert) 0.4 mg for intracanalicular use. The study, published in Patient Preference and Adhe…

Read the full story

Wednesday, March 22, 2017 | Miscellaneous, Prevent Blindness

April Declared Women’s Eye Health and Safety Awareness Month

More women than men have eye disease, including age-related macular degeneration (AMD), cataracts, and glaucoma. According to the Prevent Blindness study, "The Future of Vision: Forecasting the P…

Read the full story

Wednesday, March 22, 2017 | Glaucoma, Medical Studies

Body-tilt Test Helps Predict Optic Nerve Tissue Loss in Glaucoma

Changes in pattern electroretinogram (PERG) and other measures associated with head-down-body-tilt (HDT) position predict future loss of optic nerve tissue in individuals at risk for glaucoma, accordi…

Read the full story

Wednesday, March 22, 2017 | Clinical Trials, Management/Leadership

ClarVista Medical Completes Milestone to Advance Novel Modular Intraocular Lens for Cataract Lens Replacement

ClarVista Medical, a privately-held ophthalmic device company developing the Harmoni Modular IOL System, a novel IOL used to restore vision after cataract surgery, announced that several feasibility t…

Read the full story

Wednesday, March 22, 2017 | Miscellaneous

Physician Who Tricked Patients Into Surgery Gets 10 Years

Ophthalmologist David Ming Pon, MD, MPH, was sentenced last week in a federal district court in Jacksonville, Florida, to 10 years in prison for bilking Medicare out of nearly $10 million. One could c…

Read the full story

Tuesday, March 21, 2017 | Health Care, Prevent Blindness

Prevent Blindness Urges Secretary Price to Prioritize Eye and Vision Health

In a letter to the newly confirmed US Department of Health and Human Services Secretary Thomas Price, Prevent Blindness urged the secretary to prioritize adult and children’s vision health in co…

Read the full story

Tuesday, March 21, 2017 | Medical Studies

"Living with Sjögren's" Survey Demonstrates Impact Sjögren’s Has on Ability to Function at Home and At Work

For the overwhelming majority of patients living with Sjögren’s, an autoimmune disorder affecting more than 4 million Americans (90% of whom are women), every day is a challenge in coping w…

Read the full story

Tuesday, March 21, 2017 | Medical Studies

China’s Ophthalmic Market to Grow to $4 Billion by 2022

Market Scope forecasts that China’s $2.7 billion ophthalmic market will grow at a compound annual rate of 8.5 percent to $4 billion in 2022 in constant currency terms. China, the most populous c…

Read the full story

Tuesday, March 21, 2017 | Miscellaneous, American Academy of Ophthalmology

American Academy of Ophthalmology Statement on Stem Cell Therapy for Treating Eye Disease

A recent article in the New England Journal of Medicine highlights concerns that the American Academy of Ophthalmology has previously expressed regarding stem cell therapy for diseases of the retina. …

Read the full story

Tuesday, March 21, 2017 | CE Mark Approval

Sanoculis Receives CE Mark for its Minimally Invasive Micro Sclerostomy (MIMS) Device

Sanoculis has announced that its minimally invasive micro sclerostomy (MIMS) device and procedure has been granted the CE marking, enabling market launch in Europe. Sanoculis now plans to conduct a la…

Read the full story

Tuesday, March 21, 2017 | Glaucoma, Bausch+Lomb, Nicox

Bausch + Lomb and Nicox Announce PDUFA Date For Novel Glaucoma Candidate Latanoprostene Bunod

Bausch + Lomb and Nicox announced that the FDA has set a deadline of August 24, 2017 for its decision on the new drug application for latanoprostene bunod ophthalmic solution, 0.024%. Latanoprostene b…

Read the full story

Monday, March 20, 2017 | Cataract Surgery, Medical Studies, Imprimis Pharmaceuticals

Peer-Reviewed Paper Demonstrates the Benefits of Dropless Cataract Surgery

Imprimis Pharmaceuticals, an ophthalmology-focused pharmaceutical company, today announced the publication of a dropless therapy article in the peer-reviewed journal, Current Pharmaceutical Desig…

Read the full story

Friday, March 17, 2017 | Laser Vision Correction, Carl Zeiss Meditec

First SMILE Laser Eye Surgery Procedure Performed on US Service Members Expands Vision Correction Options for Myopia in the Department of Defense

Fort Belvoir Community Hospital in Virginia is the first US Department of Defense (DoD) medical facility to perform the revolutionary laser vision correction procedure, ReLEx SMILE from Zeiss. The Nav…

Read the full story
Load More